We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Bench Top Protein Purification System Reduces Human Operator Variability

By LabMedica International staff writers
Posted on 12 May 2010
Preparation of purified proteins from cell lysates or bacterial cultures has been rendered easier and more reproducible following the development of a bench top automated protein purification system.

Protein purification with the Invitrogen (part of Life Technologies Corporation (Carlsbad, CA, USA)) MAGic Sample Processor is based on separation protocols using "Dynabeads” magnetic (hence the capitalized MAG in MAGic) particles.

The MAGic Sample Processor incorporates innovative microfluidics, thermal controls, and integrated magnetic separation technology, which allows investigators to automate protein purification methods easily without relying on centralized facilities. More...
The benchtop system is capable of simultaneously handling 12 samples using a proprietary cartridge to reduce the variability commonly attributed with traditional manual approaches, and easily runs standard or customized protocols. Additionally, the system is combined with new reagents based on the company's leading proprietary Dynabeads magnetic separation technology.

"The MAGic Sample Processor is designed to address reproducibility challenges in research,” said Nicolas Barthelemy, president of the cell systems division at Life Technologies. "Scientists are under pressure to be more productive and MAGic, along with our other bench top devices such as the iBlot Dry Blotting Device and the BenchPro 4100 Western Processing Device, is enabling researchers to spend less time doing repetitive work and more time where it matters - analyzing their results.”

Related Links:
Life Technologies Corporation




Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
cDNA Synthesis Kit
Ultimate cDNA Synthesis Kit
New
Glucose Tolerance Test
NERL Trutol
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Switching to an experimental drug after liquid biopsy detection of breast cancer recurrence can improve outcomes (Photo courtesy of Shutterstock)

Treatment Switching Guided by Liquid Biopsy Blood Tests Improves Outcomes for Breast Cancer Patients

Standard treatment for patients with advanced estrogen receptor (ER)-positive, HER2-negative breast cancer, a subtype driven by estrogen receptors that fuel tumor growth, often involves aromatase inhibitors,... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.